Evidence map›Paper›PMID 36404981›Full record

ArticleInternational journal of ophthalmology2022

Effect of FFP2/N95 facemask wear on retinal and choroidal thickness profile in healthy subjects.

Betul Onal Gunay, Irfan Akalin, Ahmet Kalkisim, Cenap Mahmut Esenulku, Elif Betul Turkoglu

Open access · goldAbstract read
In one paragraph

Article in International journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 3 countries.

Betul Onal GunayDepartment of Ophthalmology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon 61040, Turkey.
Irfan AkalinDepartment of Ophthalmology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon 61040, Turkey.
Ahmet KalkisimDepartment of Ophthalmology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon 61040, Turkey.
Cenap Mahmut EsenulkuDepartment of Ophthalmology, University of Health Sciences, Trabzon Kanuni Training and Research Hospital, Trabzon 61040, Turkey.
Elif Betul TurkogluDepartment of Ophthalmology, Akdeniz University Hospital, Antalya 07070, Turkey.
Akdeniz University Hospital · TRSağlık Bilimleri Üniversitesi · TRUni Research (Norway) · NOUniversity of Health Sciences Antigua · AG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the influence of non-oil 95 (N95)/filtering facepiece 2 (FFP2) facemask wear on retinal thickness, choroidal thickness (CT), retinal nerve fiber layer thickness (RNFLT), and ganglion cell layer thickness (GCLT) in healthy subjects.

methodsIn this prospective study, 53 healthy participants who used FFP2/N95 facemask were enrolled. Participants underwent optical coherence tomography imaging before and at 1 and 4h following FFP2/N95 facemask wear. The last imaging session was performed 1h after FFP2/N95 removal. Retinal thickness, CT, RNFLT, and GCLT were assessed at each session. Vital parameters were also assessed.

resultsThe pulse rate of the subjects significantly decreased at 1 and 4h compared to baseline values (

conclusionParasympathetic activation during FFP2/N95 facemask wear might have a role on elevated CT measurements in healthy individuals by virtue of increased choroidal blood flow.

Indexed as

choroidFFP2/N95 facemaskganglion cell layerretinaretinal nerve fiber layerthickness

Identifiers

PMID36404981
PMCPMC9631179
OpenAlexW4307247887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.